biote Corp (BTMD)
Healthcare
Medical Care Facilities
2.30 $
+1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns biote Corp (BTMD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 64.7% of the shares are freely tradable; institutional investors hold 66.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
66.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
10.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
64.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
30Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| 325 Capital LLC | 14.99 | 4,548,127 | +0.0 | 03/31/2026 |
| Bandera Partners LLC | 6.81 | 2,065,482 | -9.6 | 03/31/2026 |
| BlackRock Inc | 5.73 | 1,739,244 | -1.7 | 03/31/2026 |
| Vanguard Group Inc | 4.76 | 1,444,733 | +1.2 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.67 | 1,113,855 | +0.0 | 03/31/2026 |
| Acadian Asset Management LLC | 2.30 | 697,855 | +15,505.0 | 03/31/2026 |
| State Street Corp | 2.13 | 646,954 | +7.8 | 03/31/2026 |
| Geode Capital Management, LLC | 2.03 | 615,662 | -0.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.74 | 829,704 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 2.21 | 670,222 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.